Publications by authors named "Hongwei Ling"

Claim this Profile
E
Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial.
Dalong Zhu, Jianhua Ma, Weimin Wang, Bimin Shi, Xiaolin Dong, Hongwei Ling

Diabetologia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial.
Yang He, Nianrong Mi, Zhifeng Cheng, Haibo Xue, Jie Han, Hongwei Ling

Lancet Diabetes Endocrinol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of insulin degludec biosimilar B01411 versus originator insulin degludec in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs: a multicenter, randomized, open-label, phase 3 study.
Linong Ji, Leili Gao, Zhifeng Cheng, Guoqing Ma, Shu Li, Hongwei Ling

Curr Med Res Opin· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hsa_circ_0008500 inhibits apoptosis of adipose-derived stem cells under high glucose through hsa-miR-1273h-5p/ELK1 axis.
Fandong Meng, Fengjie Shen, Xuan Chu, Hongwei Ling, Yun Qiao

Environ Toxicol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of DBPR108 (prusogliptin) as an add-on to metformin therapy in patients with type 2 diabetes: A 24-week, multi-centre, randomized, double-blind, placebo-controlled, superiority, phase III clinical trial.
Jianping Xu, Hongwei Ling, Jianlin Geng, , Yanli Huang

Diabetes Obes Metab· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of gene variants on the therapeutic responses to exenatide in chinese patients with type 2 diabetes mellitus.
Jinfang Song, Na Li, Ruonan Hu, Yanan Yu, Ke Xu, Hongwei Ling

Front Endocrinol (Lausanne)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CircARHGAP12 Triggers Mesenchymal Stromal Cell Autophagy to Facilitate its Effect on Repairing Diabetic Wounds by Sponging miR-301b-3p/ATG16L1 and miR-301b-3p/ULK2.
Fandong Meng, Fengjie Shen, Hongwei Ling, Peisheng Jin, Dongmei Zhou

J Invest Dermatol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma.
Jin Jin, Guihua Wu, Chengwei Ruan, Hongwei Ling, Xueman Zheng

J Clin Lab Anal· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age Moderates the Impact of TRAbs on Thyroid Hormones and Hepatic Function in Patients with Graves' Disease.
Kai Guo, Hongwei Ling, Xiaoyan Zhou, Changjiang Ying

Horm Metab Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors associated with glycaemic response to exenatide in Chinese patients with type 2 diabetes mellitus.
Tao Wang, Fan Zhang, Xiaotong Wang, Xizhi Li, Hongwei Ling

J Clin Pharm Ther· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycemic variability indices determined by self-monitoring of blood glucose are associated with β-cell function in Chinese patients with type 2 diabetes.
Yusheng Zhang, Jiao Dai, Xiao Han, Yue Zhao, Hui Zhang, Hongwei Ling

Diabetes Res Clin Pract· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Gene Polymorphisms Are Associated With the Therapeutic Responses to Repaglinide in Chinese Patients With Type 2 Diabetes Mellitus.
Tao Wang, Xiao-Tong Wang, Ran Lai, Hong-Wei Ling, Fan Zhang

Front Pharmacol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose fluctuation increased mesangial cell apoptosis related to AKT signal pathway.
Changjiang Ying, Shanshan Wang, Yan Lu, Lei Chen, Yizhen Mao, Hongwei Ling

Arch Med Sci· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bamboo leaf extract ameliorates diabetic nephropathy through activating the AKT signaling pathway in rats.
Changjiang Ying, Yizhen Mao, Lei Chen, Shanshan Wang, Hongwei Ling

Int J Biol Macromol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose variability aggravates cardiac fibrosis by altering AKT signalling path.
Changjiang Ying, Ting Liu, Hongwei Ling, Mingyue Cheng, Xiaoyan Zhou

Diab Vasc Dis Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zeaxanthin ameliorates high glucose-induced mesangial cell apoptosis through inhibiting oxidative stress via activating AKT signalling-pathway.
Changjiang Ying, Lei Chen, Shanshan Wang, Yizhen Mao, Hongwei Ling

Biomed Pharmacother· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood glucose fluctuation accelerates renal injury involved to inhibit the AKT signaling pathway in diabetic rats.
Changjiang Ying, Xiaoyan Zhou, Zhenzhen Chang, Hongwei Ling, Xingbo Cheng

Endocrine· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis